source
- Experts discuss the evolving role of radiopharmaceuticals in advanced prostate cancerDr. Pedro Barata and Dr. Johann de Bono wrapped up a series on metastatic castration-resistant prostate cancer by looking ahead to how radiopharmaceutical treatments may shape care. They highlight…
- Experts highlight growing complexity of personalized therapy choices for metastatic castration-resistant prostate cancerDr. Johann De Bono and Dr. Pedro Barata discuss how treatment decisions for metastatic castration-resistant prostate cancer are becoming more intricate as new radiopharmaceuticals and targeted agen…